Drugs Made In America Acquisition II Corp. (DMII)

Drugs Made In America Acquisition II will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
50,000,000
Deal Size
$500.00M
Chart not available yet
Data will show when the stock starts trading.
Market Cap637.00M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out 63.70M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About DMII

Drugs Made In America Acquisition II is a blank check company newly incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. We intend to focus our search for business combination targets in the pharmaceutical industry. [Read more]

Sector Financials
Founded 2024
Country United States
Stock Exchange NASDAQ
Ticker Symbol DMII
Full Company Profile

News

SPAC Drugs Made In America Acquisition II files for a $500 million IPO, targeting pharmaceuticals

Drugs Made In America Acquisition II, a blank check company targeting the pharmaceutical industry, filed on Monday with the SEC to raise up to $500 million in an initial public offering.

3 days ago - Renaissance Capital

Drugs Made In America Acquisition II IPO Registration Document (S-1)

Drugs Made In America Acquisition II has filed to go public with an IPO on the NASDAQ.

6 days ago - SEC